Propecia Generic For Male Pattern Baldness

The drug propecia generic was originally intended for treating prostate enlargement or benign prostatic hyperplasia. When its branded name Proscar was released in the market, it was noticed that men who were suffering from androgenic alopecia were also being treated by the drug.  It was then that the manufacturer took notice and created some clinical studies and found out that Proscar, which came at 5mg, which at lowered dosage, particularly 1mg, could help fight androgenic alopecia.  Several years later, the brand Propecia, an offshoot of the drug Proscar was approved by the Food and Drug Administration as a treatment for androgenic alopecia.

Who is propecia generic intended for?

Propecia generic is meant for men suffering from male pattern baldness and want to stop the progression of their hair loss.  Signs of male pattern baldness would be the thinning of hair on the front, the receding of hairline on the temples, and the formation of a bald spot on the crown.  In due time, this type of baldness will let you end up bald from top to front with a rim of hair at the sides and back.  propecia generic is effective against this type of hair loss because it is able to treat it at the root of the cause – the formation of the hormone dihydrotestosterone (DHT).  Basically, this hair loss treatment prevents your hair loss from getting any worse.  If your hair loss is due to androgenic alopecia, then this is the medication for you.  Consult your doctor to know what type of hair loss you are having. Read more…

Canadian-led study named top medical breakthrough of 2007

In a seemingly unlikely turn of events, a Manitoba-based physician's work has been crowned the top medical breakthrough in the entire world in 2007.

Research led by Dr Stephen Moses, who teaches microbiology and internal medicine at the University of Manitoba, received .

The study singled out for the honour found in Kenya. The Canadian Institutes of Health Research, which provided funding, is boasting today of its superb foresight.

a year ago about his research and its critics. "I think that it would be in order for the Canadian Paediatric Society (CPS) to revisit the issue of routine male circumcision, not just in the light of the findings of reduced risk for HIV infection, but in relation to other health benefits which have come to light in recent years," he said at the time.

You can read of Dr Moses on the International Centre for Infectious Diseases website, and check out more of Dr Moses's research . (Or you can read about Moses, the man who led the Jews out of Egypt in another kind of breakthrough altogether, , if you prefer. Moses was himself presumably circumcised, as Jewish custom dictates. Coincidence? Probably.)

  • 1. (research led by Dr Stephen Moses)
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.

Is Time's list accurate? I have my doubts. Is a controversial, diarrhea-inducing OTC diet drug like orlistat (Alli) really more important in the long run than advances in stem cell research or improved lung cancer testing?

That kind of question echoes one of the central problems of medical research and medical reporting: how to balance the time and money allotted to research with an immediate payoff against research that, although it probably doesn't make much of a difference right away, may lay the groundwork for true breakthroughs later on. (It's another matter entirely to consider the frequent use of the term 'breakthrough' in the pages of daily newspapers these days to describe relatively minor bits and pieces of research.)


Check out our website: